Largest companies by market cap
market cap
| Company | Market cap | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 601 | $67.73M | Healthcare | Biotechnology | United States | Nasdaq |
| 602 | $67.46M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 603 | $66.88M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 604 | $65.75M | Healthcare | Medical Devices | United States | Nasdaq |
| 605 | $65.55M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 606 | $63.26M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 607 | $62.20M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 608 | $61.80M | Healthcare | Biotechnology | United States | Nasdaq |
| 609 | $61.79M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 610 | $61.77M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 611 | $60.84M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 612 | $60.55M | Healthcare | Biotechnology | USA | Nasdaq |
| 613 | $60.03M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 614 | $59.91M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 615 | $59.45M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 616 | $59.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 617 | $58.80M | Healthcare | Pharmaceuticals | United States | NYSE |
| 618 | $57.36M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 619 | $55.69M | Healthcare | Biotechnology | United States | Nasdaq |
| 620 | $55.64M | Healthcare | Medical Devices | United States | Nasdaq |
| 621 | $55.51M | Healthcare | Biotechnology | United States | Nasdaq |
| 622 | $55.40M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 623 | $55.22M | Healthcare | Medical Devices | United States | Nasdaq |
| 624 | $53.43M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 625 | $52.67M | Healthcare | Biotechnology | United States | Nasdaq |
| 626 | $52.33M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 627 | $52.16M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 628 | $51.82M | Healthcare | Medical Devices | United States | Nasdaq |
| 629 | $51.44M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 630 | $51.05M | Healthcare | Pharmaceuticals | United States | NYSE |
| 631 | $49.65M | Healthcare | Medical Devices | United States | Nasdaq |
| 632 | $49.30M | Healthcare | Medical Devices | United States | Nasdaq |
| 633 | $48.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 634 | $47.75M | Healthcare | Biotechnology | United States | Nasdaq |
| 635 | $46.23M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 636 | $46.05M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 637 | $45.97M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 638 | $45.43M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 639 | $45.20M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 640 | $44.60M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 641 | $44.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 642 | $44.02M | Healthcare | Biotechnology | United States | Nasdaq |
| 643 | $43.77M | Healthcare | Medical Devices | United States | Nasdaq |
| 644 | $43.36M | Healthcare | Medical Devices | United States | Nasdaq |
| 645 | $43.16M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 646 | $43.07M | Healthcare | Biotechnology | United States | Nasdaq |
| 647 | $43.05M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 648 | $42.87M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 649 | $41.35M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 650 | $41.30M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 651 | $41.22M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 652 | $40.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 653 | $39.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 654 | $39.14M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 655 | $38.63M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 656 | $38.13M | Healthcare | Biotechnology | United States | Nasdaq |
| 657 | $37.96M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 658 | $37.53M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 659 | $37.10M | Healthcare | Pharmaceuticals | United States | NYSE |
| 660 | $36.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 661 | $36.38M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 662 | $36.33M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 663 | $36.15M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 664 | $36.11M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 665 | $35.81M | Healthcare | Medical Devices | United States | Nasdaq |
| 666 | $35.19M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 667 | $34.99M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 668 | $34.78M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 669 | $33.54M | Healthcare | Healthcare Providers | United States | NYSE |
| 670 | $32.05M | Healthcare | Medical Devices | United States | Nasdaq |
| 671 | $30.76M | Healthcare | Pharmaceuticals | United States | NYSE |
| 672 | $30.46M | Healthcare | Pharmaceutical Retailers | United States | Nasdaq |
| 673 | $30.34M | Healthcare | Medical Devices | United States | Nasdaq |
| 674 | $29.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 675 | $29.90M | Healthcare | Biotechnology | United States | NYSE |
| 676 | $29.63M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 677 | $29.49M | Healthcare | Biotechnology | United States | Nasdaq |
| 678 | $29.20M | Healthcare | Biotechnology | United States | Nasdaq |
| 679 | $28.95M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 680 | $28.33M | Healthcare | Pharmaceuticals | United States | NYSE |
| 681 | $27.94M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 682 | $27.04M | Healthcare | Biotechnology | United States | Nasdaq |
| 683 | $24.85M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 684 | $24.19M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 685 | $23.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 686 | $23.31M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 687 | $23.25M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 688 | $21.02M | Healthcare | Medical Devices | United States | Nasdaq |
| 689 | $20.83M | Healthcare | Biotechnology | United States | Nasdaq |
| 690 | $20.57M | Healthcare | Medical Devices | United States | NYSE |
| 691 | $19.79M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 692 | $19.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 693 | $19.75M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 694 | $19.60M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 695 | $19.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 696 | $19.56M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 697 | $18.76M | Healthcare | Biotechnology | United States | Nasdaq |
| 698 | $18.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 699 | $18.38M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 700 | $17.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 889 companies. Market capitalization in USD.